Hzymes developed a nucleic acid fluorescent substrate method for detecting DNase/RNase residues in biologics. This method addresses three major technical challenges: 1. Coverage of different DNase/RNase types. 2. Enhanced detection sensitivity. 3. Applicability to complex samples.

Hzymes has solidified its position as a leader in mRNA synthesis and drug development. Its comprehensive solutions, cost-effective approaches, and strong regulatory compliance set it apart in an increasingly competitive market.

HZYMES Biotech offers a highly flexible and customizable service for mRNA synthesis and LNP preparation, helping clients overcome the challenges of mRNA delivery and stability.

HZYMES, offers a comprehensive suite of services to ensure high-quality mRNA production. This article outlines the step-by-step process provided by HZYMES, from template preparation to quality control, emphasizing each service’s critical role in mRNA development.